Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RUFY2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MFSD6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CLASP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
AGTPBP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
REPS2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP2C1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
IMPAD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PAFAH1B1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM30A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GSPT1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ANKRD13C - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RUFY3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SCD5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ABCE1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CDC42SE2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SC5D - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
COX18 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PGRMC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PAFAH1B2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATMIN - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on